Cargando…

Magnetic Targeting of HU-MSCs in the Treatment of Glucocorticoid-Associated Osteonecrosis of the Femoral Head Through Akt/Bcl2/Bad/Caspase-3 Pathway

PURPOSE: Osteonecrosis of the femoral head (ONFH) is a chronic and irreversible disease that eventually develops into a joint collapse and results in joint dysfunction. Early intervention and treatment are essential for preserving the joints and avoiding hip replacement. In this study, a system of h...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Lian, Zuo, Jianlin, Zhang, Fuqiang, Li, Binxi, Xu, Zhonghang, Zhang, Hao, Yang, Bai, Song, Wenzhi, Jiang, Jinlan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247730/
https://www.ncbi.nlm.nih.gov/pubmed/32547017
http://dx.doi.org/10.2147/IJN.S244453
_version_ 1783538221371621376
author Duan, Lian
Zuo, Jianlin
Zhang, Fuqiang
Li, Binxi
Xu, Zhonghang
Zhang, Hao
Yang, Bai
Song, Wenzhi
Jiang, Jinlan
author_facet Duan, Lian
Zuo, Jianlin
Zhang, Fuqiang
Li, Binxi
Xu, Zhonghang
Zhang, Hao
Yang, Bai
Song, Wenzhi
Jiang, Jinlan
author_sort Duan, Lian
collection PubMed
description PURPOSE: Osteonecrosis of the femoral head (ONFH) is a chronic and irreversible disease that eventually develops into a joint collapse and results in joint dysfunction. Early intervention and treatment are essential for preserving the joints and avoiding hip replacement. In this study, a system of human umbilical mesenchymal stem cells-supermagnetic iron oxide nanoparticles (NPs) @polydopamine (SCIOPs) was constructed. The magnetic targeting system gathers in the lesion area, inhibits the apoptosis of bone cells, enhances osteogenic effect, and effectively treats ONFH under external magnetic field. MATERIALS AND METHODS: The supermagnetic iron oxide NPs @polydopamine (SPION@PDA NPs) were characterized by transmission electron microscopy and zeta potential, respectively. The effects of SPION@PDA NPs on the viability, proliferation, and differentiation of stem cells were detected by the CCK8 method, flow cytometry, and staining, respectively. The serum inflammatory indicators were detected by Luminex method. The bone mass of the femoral head was analyzed by micro computed tomography. The expression of apoptosis and osteoblast-related cytokines was detected by Western blotting. The osteogenesis of the femoral head was detected by histological and immunohistochemical sections. RESULTS: The SCIOPs decreased the pro-inflammatory factors, and the micro CT showed that the bone repair of the femoral head was enhanced after treatment. The hematoxylin and eosin sections also showed an increase in the osteogenesis in the femoral head. Western blotting results showed and increased expression of anti-apoptotic proteins Akt and Bcl-2, decreased expression of apoptotic proteins caspase-3 and Bad, and increased expression of osteogenic proteins Runx-2 and Osterix in the femoral head. CONCLUSION: Under the effect of magnetic field and homing ability of stem cells, SCIOPs inhibited the apoptosis of osteoblasts, improved the proliferation ability of osteoblasts, and promoted bone repair in the femoral head through the Akt/Bcl-2/Bad/caspase-3 signaling pathway, thereby optimizing the tissue repair ability.
format Online
Article
Text
id pubmed-7247730
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-72477302020-06-15 Magnetic Targeting of HU-MSCs in the Treatment of Glucocorticoid-Associated Osteonecrosis of the Femoral Head Through Akt/Bcl2/Bad/Caspase-3 Pathway Duan, Lian Zuo, Jianlin Zhang, Fuqiang Li, Binxi Xu, Zhonghang Zhang, Hao Yang, Bai Song, Wenzhi Jiang, Jinlan Int J Nanomedicine Original Research PURPOSE: Osteonecrosis of the femoral head (ONFH) is a chronic and irreversible disease that eventually develops into a joint collapse and results in joint dysfunction. Early intervention and treatment are essential for preserving the joints and avoiding hip replacement. In this study, a system of human umbilical mesenchymal stem cells-supermagnetic iron oxide nanoparticles (NPs) @polydopamine (SCIOPs) was constructed. The magnetic targeting system gathers in the lesion area, inhibits the apoptosis of bone cells, enhances osteogenic effect, and effectively treats ONFH under external magnetic field. MATERIALS AND METHODS: The supermagnetic iron oxide NPs @polydopamine (SPION@PDA NPs) were characterized by transmission electron microscopy and zeta potential, respectively. The effects of SPION@PDA NPs on the viability, proliferation, and differentiation of stem cells were detected by the CCK8 method, flow cytometry, and staining, respectively. The serum inflammatory indicators were detected by Luminex method. The bone mass of the femoral head was analyzed by micro computed tomography. The expression of apoptosis and osteoblast-related cytokines was detected by Western blotting. The osteogenesis of the femoral head was detected by histological and immunohistochemical sections. RESULTS: The SCIOPs decreased the pro-inflammatory factors, and the micro CT showed that the bone repair of the femoral head was enhanced after treatment. The hematoxylin and eosin sections also showed an increase in the osteogenesis in the femoral head. Western blotting results showed and increased expression of anti-apoptotic proteins Akt and Bcl-2, decreased expression of apoptotic proteins caspase-3 and Bad, and increased expression of osteogenic proteins Runx-2 and Osterix in the femoral head. CONCLUSION: Under the effect of magnetic field and homing ability of stem cells, SCIOPs inhibited the apoptosis of osteoblasts, improved the proliferation ability of osteoblasts, and promoted bone repair in the femoral head through the Akt/Bcl-2/Bad/caspase-3 signaling pathway, thereby optimizing the tissue repair ability. Dove 2020-05-21 /pmc/articles/PMC7247730/ /pubmed/32547017 http://dx.doi.org/10.2147/IJN.S244453 Text en © 2020 Duan et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Duan, Lian
Zuo, Jianlin
Zhang, Fuqiang
Li, Binxi
Xu, Zhonghang
Zhang, Hao
Yang, Bai
Song, Wenzhi
Jiang, Jinlan
Magnetic Targeting of HU-MSCs in the Treatment of Glucocorticoid-Associated Osteonecrosis of the Femoral Head Through Akt/Bcl2/Bad/Caspase-3 Pathway
title Magnetic Targeting of HU-MSCs in the Treatment of Glucocorticoid-Associated Osteonecrosis of the Femoral Head Through Akt/Bcl2/Bad/Caspase-3 Pathway
title_full Magnetic Targeting of HU-MSCs in the Treatment of Glucocorticoid-Associated Osteonecrosis of the Femoral Head Through Akt/Bcl2/Bad/Caspase-3 Pathway
title_fullStr Magnetic Targeting of HU-MSCs in the Treatment of Glucocorticoid-Associated Osteonecrosis of the Femoral Head Through Akt/Bcl2/Bad/Caspase-3 Pathway
title_full_unstemmed Magnetic Targeting of HU-MSCs in the Treatment of Glucocorticoid-Associated Osteonecrosis of the Femoral Head Through Akt/Bcl2/Bad/Caspase-3 Pathway
title_short Magnetic Targeting of HU-MSCs in the Treatment of Glucocorticoid-Associated Osteonecrosis of the Femoral Head Through Akt/Bcl2/Bad/Caspase-3 Pathway
title_sort magnetic targeting of hu-mscs in the treatment of glucocorticoid-associated osteonecrosis of the femoral head through akt/bcl2/bad/caspase-3 pathway
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247730/
https://www.ncbi.nlm.nih.gov/pubmed/32547017
http://dx.doi.org/10.2147/IJN.S244453
work_keys_str_mv AT duanlian magnetictargetingofhumscsinthetreatmentofglucocorticoidassociatedosteonecrosisofthefemoralheadthroughaktbcl2badcaspase3pathway
AT zuojianlin magnetictargetingofhumscsinthetreatmentofglucocorticoidassociatedosteonecrosisofthefemoralheadthroughaktbcl2badcaspase3pathway
AT zhangfuqiang magnetictargetingofhumscsinthetreatmentofglucocorticoidassociatedosteonecrosisofthefemoralheadthroughaktbcl2badcaspase3pathway
AT libinxi magnetictargetingofhumscsinthetreatmentofglucocorticoidassociatedosteonecrosisofthefemoralheadthroughaktbcl2badcaspase3pathway
AT xuzhonghang magnetictargetingofhumscsinthetreatmentofglucocorticoidassociatedosteonecrosisofthefemoralheadthroughaktbcl2badcaspase3pathway
AT zhanghao magnetictargetingofhumscsinthetreatmentofglucocorticoidassociatedosteonecrosisofthefemoralheadthroughaktbcl2badcaspase3pathway
AT yangbai magnetictargetingofhumscsinthetreatmentofglucocorticoidassociatedosteonecrosisofthefemoralheadthroughaktbcl2badcaspase3pathway
AT songwenzhi magnetictargetingofhumscsinthetreatmentofglucocorticoidassociatedosteonecrosisofthefemoralheadthroughaktbcl2badcaspase3pathway
AT jiangjinlan magnetictargetingofhumscsinthetreatmentofglucocorticoidassociatedosteonecrosisofthefemoralheadthroughaktbcl2badcaspase3pathway